Annual Total Debt
$45.07 M
-$6.43 M-12.49%
31 December 2023
Summary:
Foghorn Therapeutics annual total debt is currently $45.07 million, with the most recent change of -$6.43 million (-12.49%) on 31 December 2023. During the last 3 years, it has fallen by -$36.92 million (-45.03%). FHTX annual total debt is now -45.03% below its all-time high of $82.00 million, reached on 31 December 2020.FHTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$39.07 M
-$1.85 M-4.51%
30 September 2024
Summary:
Foghorn Therapeutics quarterly total debt is currently $39.07 million, with the most recent change of -$1.85 million (-4.51%) on 30 September 2024. Over the past year, it has dropped by -$8.01 million (-17.02%). FHTX quarterly total debt is now -52.58% below its all-time high of $82.40 million, reached on 31 March 2021.FHTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.5% | -17.0% |
| 3 y3 years | -45.0% | -51.1% |
| 5 y5 years | +541.2% | +100.0% |
FHTX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.0% | at low | -51.1% | at low |
| 5 y | 5 years | -45.0% | +541.2% | -52.6% | |
| alltime | all time | -45.0% | +541.2% | -52.6% |
Foghorn Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $39.07 M(-4.5%) |
| June 2024 | - | $40.92 M(-4.8%) |
| Mar 2024 | - | $42.98 M(-4.6%) |
| Dec 2023 | $45.07 M(-12.5%) | $45.07 M(-4.3%) |
| Sept 2023 | - | $47.08 M(-1.8%) |
| June 2023 | - | $47.94 M(-3.8%) |
| Mar 2023 | - | $49.84 M(-3.2%) |
| Dec 2022 | $51.51 M(-11.7%) | $51.51 M(-3.1%) |
| Sept 2022 | - | $53.17 M(-3.0%) |
| June 2022 | - | $54.81 M(-3.1%) |
| Mar 2022 | - | $56.58 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $58.33 M(-28.9%) | $58.33 M(-27.0%) |
| Sept 2021 | - | $79.92 M(-2.3%) |
| June 2021 | - | $81.77 M(-0.8%) |
| Mar 2021 | - | $82.40 M(+0.5%) |
| Dec 2020 | $82.00 M(+393.1%) | $82.00 M(+15.7%) |
| Sept 2020 | - | $70.89 M(+7.9%) |
| June 2020 | - | $65.70 M(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $16.63 M(+136.6%) | $16.63 M(>+9900.0%) |
| Sept 2019 | - | $0.00 |
| Dec 2018 | $7.03 M | - |
FAQ
- What is Foghorn Therapeutics annual total debt?
- What is the all time high annual total debt for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual total debt year-on-year change?
- What is Foghorn Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly total debt year-on-year change?
What is Foghorn Therapeutics annual total debt?
The current annual total debt of FHTX is $45.07 M
What is the all time high annual total debt for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual total debt is $82.00 M
What is Foghorn Therapeutics annual total debt year-on-year change?
Over the past year, FHTX annual total debt has changed by -$6.43 M (-12.49%)
What is Foghorn Therapeutics quarterly total debt?
The current quarterly total debt of FHTX is $39.07 M
What is the all time high quarterly total debt for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly total debt is $82.40 M
What is Foghorn Therapeutics quarterly total debt year-on-year change?
Over the past year, FHTX quarterly total debt has changed by -$8.01 M (-17.02%)